BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Gore enrolls 1st patient in its REVISE clinical study

Sep. 30, 2008
By Omar Ford

Synvista test helps predict cardio risk for diabetics

Sep. 25, 2008
By Omar Ford
Synvista Therapeutics (Montvale, New Jersey) reported favorable findings from a study that indicated its proporietary monoclonal enzyme immunoassay can help in predicting cardiovascular risk in patients with diabetes. (Diagnostics & Imaging Week)
Read More

Synvista test helps predict cardio risk for diabetics

Sep. 23, 2008
By Omar Ford

Peak Surgical's PlasmaBlade is an alternative to scalpel

Sep. 22, 2008
By Omar Ford

Human hair protein found to reduce hemorrhaging

Sep. 17, 2008
By Omar Ford
ATLANTA – Can the key to reducing hemorrhaging in a wounded patient be found in a single strand of hair? A group of researchers from Wake Forest Institute for Regenerative Medicine (Winston-Salem, North Carolina) are in the process of testing that theory and displayed their findings at the Society for Biomaterials (Mount Laurel, New Jersey) Translational Research Symposium held at the Hyatt this past weekend. (Medical Device Daily)
Read More

Start-ups less likely to get biomaterials than 'big guys'

Sep. 16, 2008
By Omar Ford
ATLANTA — Can a company actually build a medical device that will go into a patient out of the biomaterials it wants to? (Medical Device Daily)
Read More

Tips given for innovating in rapidly changing landscape

Sep. 15, 2008
By Omar Ford
ATLANTA – The Society for Biomaterials (Mount Laurel, New Jersey) Translational Biomaterial Research conference, titled "Advancing Discoveries from the Laboratories to the Clinic," addressed the role of med-tech innovation in the future of healthcare. (Medical Device Daily)
Read More

ThermoSuit to be key system used in brain trauma study

Sep. 12, 2008
By Omar Ford

After FDA's PAS-Port OK, Cardica shares jump by 35%

Sep. 10, 2008
By Omar Ford

Pathway set to ride Jetstream across expanding PAD market

Sep. 8, 2008
By Omar Ford
Previous 1 2 … 204 205 206 207 208 209 210 211 212 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 13, 2026.
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing